Clinical Trial Update: Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of single doses of VBY-376 in healthy adults, completed to support development for chronic hepatitis C …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• VBY-376

Snippet

Sponsor: Virobay Inc. | Conditions: Chronic Hepatitis C Infection | Phase 1 | Status: COMPLETED